down arrow

Medikit Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3921060004
JPY
2,835.00
-12 (-0.42%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
22,553.24
21,850.54
21,607.23
20,130.70
19,312.66
19,893.20
18,501.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
22,553.24
21,850.54
21,607.23
20,130.70
19,312.66
19,893.20
18,501.80
Raw Material Cost
14,222.07
13,429.46
13,560.68
12,185.56
11,949.44
11,808.89
11,041.82
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
7.36
0.00
0.00
0.00
Selling and Distribution Expenses
3,574.18
3,468.76
3,609.32
3,198.55
3,231.22
3,542.42
3,364.68
Other Expenses
27.15
27.84
32.31
32.06
35.80
21.85
23.94
Total Expenditure (Excl Depreciation)
18,067.80
17,176.66
17,493.10
15,712.07
15,538.65
15,569.85
14,645.89
Operating Profit (PBDIT) excl Other Income
4485.400000000001
4673.9
4114.1
4418.6
3774
4323.3
3855.8999999999996
Other Income
174.32
27.15
52.23
112.12
154.88
11.62
71.37
Operating Profit (PBDIT)
6,349.40
6,245.70
5,490.09
5,800.66
5,237.56
5,653.52
5,105.56
Interest
0.00
0.00
0.00
7.36
0.00
0.00
0.00
Exceptional Items
-0.06
74.12
124.97
-50.58
0.00
0.00
-34.31
Gross Profit (PBDT)
8,331.17
8,421.09
8,046.55
7,945.14
7,363.22
8,084.31
7,459.98
Depreciation
1,689.65
1,544.66
1,323.73
1,269.91
1,308.67
1,318.56
1,178.28
Profit Before Tax
4,659.70
4,775.16
4,291.34
4,472.80
3,928.89
4,334.96
3,892.97
Tax
1,646.16
1,705.69
1,426.75
1,479.79
1,269.88
1,446.97
1,316.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
2,576.36
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
2,576.36
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,013.54
3,069.47
2,864.59
2,993.02
2,659.01
2,887.99
2,576.36
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
45,156.02
44,128.54
47,291.98
45,772.32
43,636.63
42,169.15
40,048.92
Earnings per share (EPS)
204.56
187.95
170.67
178.15
157.37
170.33
151.96
Diluted Earnings per share
204.56
187.95
170.67
178.15
157.37
170.33
151.96
Operating Profit Margin (Excl OI)
19.89%
21.39%
19.04%
21.95%
19.54%
21.73%
20.84%
Gross Profit Margin
28.15%
28.92%
25.99%
28.53%
27.12%
28.42%
27.41%
PAT Margin
13.36%
14.05%
13.26%
14.87%
13.77%
14.52%
13.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 3.22% vs 1.13% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -1.82% vs 7.15% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -0.70% vs 14.35% in Mar 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Medikit Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
22,553.24
40,539.00
-17,985.76
-44.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
22,553.24
40,539.00
-17,985.76
-44.37%
Raw Material Cost
14,222.07
24,027.00
-9,804.93
-40.81%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
17.00
-17.00
-100.00%
Selling and Distribution Expenses
3,574.18
9,126.00
-5,551.82
-60.84%
Other Expenses
27.15
436.90
-409.75
-93.79%
Total Expenditure (Excl Depreciation)
18,067.80
37,539.00
-19,471.20
-51.87%
Operating Profit (PBDIT) excl Other Income
4,485.44
3,000.00
1,485.44
49.51%
Other Income
174.32
258.00
-83.68
-32.43%
Operating Profit (PBDIT)
6,349.40
5,812.00
537.40
9.25%
Interest
0.00
17.00
-17.00
-100.00%
Exceptional Items
-0.06
-250.00
249.94
99.98%
Gross Profit (PBDT)
8,331.17
16,512.00
-8,180.83
-49.54%
Depreciation
1,689.65
2,554.00
-864.35
-33.84%
Profit Before Tax
4,659.70
2,991.00
1,668.70
55.79%
Tax
1,646.16
763.00
883.16
115.75%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,013.54
2,228.00
785.54
35.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,013.54
2,228.00
785.54
35.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,013.54
2,228.00
785.54
35.26%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
45,156.02
43,598.00
1,558.02
3.57%
Earnings per share (EPS)
204.56
64.27
140.29
218.28%
Diluted Earnings per share
204.56
64.27
140.29
218.28%
Operating Profit Margin (Excl OI)
19.89%
7.40%
0.00
12.49%
Gross Profit Margin
28.15%
13.68%
0.00
14.47%
PAT Margin
13.36%
5.50%
0.00
7.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,255.32 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 3.22% vs 1.13% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 301.35 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -1.82% vs 7.15% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 617.51 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -0.70% vs 14.35% in Mar 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.89%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."